US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.7100

-0.0100-1.39%

Post-market: 0.71000.00000.00%19:31 EDT

Volume:143.70K

Turnover:102.45K

Market Cap:36.76M

PE:-0.65

High:0.7499

Open:0.7100

Low:0.7000

Close:0.7200

Loading ...

Overview Company News Filings

Xilio Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)

Xilio Therapeutics Q1 EPS $(0.18) Misses $0.10 Estimate, Sales $2.93M Miss $4.40M Estimate

Xilio Therapeutics Q1 Net Income USD -13.265 Million

THOMSON REUTERS

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting

Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress

BRIEF-Xilio Therapeutics May Offer, Sell Shares Of Common Stock Of Up To $50 Million From Time To Time

Xilio Therapeutics files $250M mixed securities shelf

Xilio Therapeutics Inc Files for Mixed Shelf of up to $250 Mln- SEC Filing

THOMSON REUTERS

Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates

Xilio Therapeutics Q4 2024 GAAP EPS $(0.20) Beats $(0.21) Estimate, Xilio Anticipates That Its Cash And Cash Equivalents Of $55.3M As Of December 31, 2024, Together With The $52M Upfront Payments Received From AbbVie Is Expected To Provide Cash Runway Into Q1 Of 2026

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN) and Xilio Therapeutics (XLO)

Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie

Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

Xilio Therapeutics Shares up 107% After Collaboration With Abbvie to Develop Cancer Treatments

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","market":"US","secType":"STK","nameCN":"XILIO THERAPEUTICS, INC.","latestPrice":0.71,"timestamp":1746820800000,"preClose":0.72,"halted":0,"volume":143699,"hourTrading":{"tag":"盘后","latestPrice":0.71,"preClose":0.71,"latestTime":"19:31 EDT","volume":300,"amount":213.4951,"timestamp":1746833506100},"delay":0,"floatShares":21991160,"shares":51773717,"eps":-1.088384,"marketStatus":"Not Yet Opened","change":-0.01,"latestTime":"05-09 16:00:00 EDT","open":0.71,"high":0.7499,"low":0.7,"amount":102446.322177,"amplitude":0.069306,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.088384,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"listingDate":1634875200000,"exchange":"NASDAQ","adjPreClose":0.72,"preHourTrading":{"tag":"盘前","latestPrice":0.7622,"preClose":0.72,"latestTime":"08:56 EDT","volume":12962,"amount":9874.032927,"timestamp":1746795368949},"postHourTrading":{"tag":"盘后","latestPrice":0.71,"preClose":0.71,"latestTime":"19:31 EDT","volume":300,"amount":213.4951,"timestamp":1746833506100},"volumeRatio":0.668481815433264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","floatShares":21991160,"roa":"-38.21%","roe":"-297.84%","lyrEps":-1.088384,"volumeRatio":0.668481815433264,"shares":51773717,"dividePrice":0,"high":0.7499,"amplitude":0.069306,"preClose":0.72,"low":0.7,"week52Low":0.62,"pbRate":"3.44","psRate":"3.96","week52High":1.7,"institutionHeld":0,"latestPrice":0.71,"eps":-1.088384,"divideRate":0,"volume":143699,"delay":0,"ttmEps":-1.088384,"open":0.71,"prevYearClose":0.955,"prevWeekClose":0.7502,"prevMonthClose":0.7657,"prevQuarterClose":0.7244,"fiveDayClose":0.7502,"twentyDayClose":0.6615,"sixtyDayClose":1.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534219480","title":"Xilio Therapeutics Inc  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534219480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534219480?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:51","pubTimestamp":1746798667,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc  expected to post a loss of16cents a share - Earnings Preview Xilio Therapeutics Inc XLO.OQ XLO.O is expected to show a rise in quarterly revenue when it reports  results on Aug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH205:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO"],"gpt_icon":0},{"id":"2534157088","title":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534157088","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534157088?lang=en_us&edition=fundamental","pubTime":"2025-05-09 01:52","pubTimestamp":1746726745,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Entrada Therapeutics Inc (TRDA – Research Report), Galmed Pharmac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-entrada-therapeutics-inc-trda-galmed-pharmaceuticals-glmd-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-entrada-therapeutics-inc-trda-galmed-pharmaceuticals-glmd-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","BK4139","XLO","BK4137","HCSG","TRDA"],"gpt_icon":0},{"id":"2533864041","title":"Xilio Therapeutics Q1 EPS $(0.18) Misses $0.10 Estimate, Sales $2.93M Miss $4.40M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533864041","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533864041?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:38","pubTimestamp":1746704338,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics (NASDAQ:XLO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $0.10 by 280 percent. This is a 69.49 percent increase over losses of $(0.59) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45282243/xilio-therapeutics-q1-eps-0-18-misses-0-10-estimate-sales-2-93m-miss-4-40m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","XLO"],"gpt_icon":0},{"id":"2533185058","title":"Xilio Therapeutics Q1 Net Income USD -13.265 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533185058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533185058?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:30","pubTimestamp":1746703800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLXE8FBBB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2532874890","title":"Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532874890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532874890?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:30","pubTimestamp":1746217800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nTUA4QSJTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2529663740","title":"Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663740?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:30","pubTimestamp":1745440200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April 23, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced plans to present updated data from its ongoing Phase 2 clinical trial investigating vilastobart, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab  in patients with metastatic microsatellite stable colorectal cancer  at the2025 American Society of Clinical Oncology Annual Meeting. The conference is being held inChicago, Illinois from May 30 to June 3, 2025.About Vilastobart and the Phase 1/2 Combination Clinical Trial. Cautionary NoteRegarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding plans to present clinical data from the Phase 2 clinical trial for vilastobart in comb","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xilio-therapeutics-present-updated-phase-203000820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","SG9999011746.SGD","BK4563","BK4552","BK4531","BK4535","BK4108","IE00B12V2V27.USD","BK4139","XLO","LU0359202008.SGD","BK4509","IE00BYQNZ168.SGD","BK4565","BK4007","LU0359201612.USD","BK4548","01698","BK4571","LU1023057109.AUD","TME","IE00BYTNYN87.SGD","LU2039709279.SGD","BK4526"],"gpt_icon":0},{"id":"2518403984","title":"Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2518403984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518403984?lang=en_us&edition=fundamental","pubTime":"2025-03-12 12:14","pubTimestamp":1741752873,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc ( ($XLO) ) has released its Q4 earnings. Here is a breakdown of the information Xilio Therapeutics Inc presented to its inve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-reports-2024-financial-results-and-pipeline-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-reports-2024-financial-results-and-pipeline-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","LU2065732104.USD","XLO","LENZ","PRGS","BK4139"],"gpt_icon":0},{"id":"2518740227","title":"BRIEF-Xilio Therapeutics  May Offer, Sell Shares Of Common Stock Of Up To $50 Million From Time To Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740227?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:23","pubTimestamp":1741702993,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics  May Offer, Sell Shares Of Common Stock Of Up To $50 Million From Time To TimeMarch 11  - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS : MAY OFFER, SELL SHARES OF COMMON STOCK OF UP TO $50 MILLION FROM TIME TO TIMEFurther company coverage: XLO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2518674177","title":"Xilio Therapeutics files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2518674177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518674177?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:40","pubTimestamp":1741700450,"startTime":"0","endTime":"0","summary":"09:35 EDT Xilio Therapeutics (XLO) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xilio-therapeutics-files-250m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xilio-therapeutics-files-250m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLO","LENZ"],"gpt_icon":0},{"id":"2518740110","title":"Xilio Therapeutics Inc Files for Mixed Shelf of up to $250 Mln- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740110?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:31","pubTimestamp":1741699895,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU086:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2518728321","title":"Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728321","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728321?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:45","pubTimestamp":1741697104,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics, Inc.  came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.09%. A quarter ago, it was expected that this company would post a loss of $0.25 per share when it actually produced a loss of $0.22, delivering a surprise of 12%.Xilio Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.72 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 23.72%. This compares to zero revenues a year ago.Xilio Therapeutics shares have lost about 11.5% since the beginning of the year versus the S&P 500's decline of -4.5%.While Xilio Therapeutics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xilio-therapeutics-inc-xlo-reports-124504233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XLO"],"gpt_icon":0},{"id":"2518440710","title":"Xilio Therapeutics Q4 2024 GAAP EPS $(0.20) Beats $(0.21) Estimate, Xilio Anticipates That Its Cash And Cash Equivalents Of $55.3M As Of December 31, 2024, Together With The $52M Upfront Payments Received From AbbVie Is Expected To Provide Cash Runway Into Q1 Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440710","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518440710?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:46","pubTimestamp":1741693582,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics (NASDAQ:XLO) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.21) by 4.76 percent. This is a 68.75 percent increase over losses of $(0.64) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44243821/xilio-therapeutics-q4-2024-gaap-eps-0-20-beats-0-21-estimate-xilio-anticipates-that-its-cash-and-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LENZ","XLO"],"gpt_icon":0},{"id":"2518402717","title":"Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518402717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518402717?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results. Additional Phase 2 data for vilastobart, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC anticipated in the middle of 2025. Advancing masked T cell engager programs in novel ATACR and SEECR formats for PSMA, CLDN18.2 and STEAP1. WALTHAM, Mass., March 11, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the fourth quarter and full year ended December 31, 2024.data cutoff date of January 13, 2025, these data demonstra","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4588","LENZ","BK4232","XLO","LU0053666078.USD","LU0359202008.SGD","SG9999011746.SGD","LU2039709279.SGD","BK4552","BK4571","BK4107","L","BK4108","BK4535","BK4509","IE00BYTNYN87.SGD","BK4139","BK4585","IE00BYQNZ168.SGD","TME","BK4531","LU0359201612.USD","01698","BK4565","R","BK4563","BK4022","IE00B12V2V27.USD","LU1023057109.AUD","BK4526"],"gpt_icon":0},{"id":"2512113200","title":"BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512113200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512113200?lang=en_us&edition=fundamental","pubTime":"2025-02-19 06:39","pubTimestamp":1739918384,"startTime":"0","endTime":"0","summary":"BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC FilingFeb 18  - Xilio Therapeutics Inc XLO.O:ABBVIE INC. REPORTS 9.0 % PASSIVE STAKE IN XILIO THERAPEUTICS, INC. AS OF FEB 11 - SEC FILINGSource text: [ID:n0001104659-25-014772]Further company coverage: XLO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P91F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2511695412","title":"Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2511695412","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511695412?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:03","pubTimestamp":1739538180,"startTime":"0","endTime":"0","summary":"Here's a recap of the week’s most important stories.Novartis, along with private firm Blackstone Life Sciences, launched Anthos Therapeutics in 2019. Anthos Therapeutics was developing abelacimab under a licensing deal with Novartis. For the recent deal, Novartis will make an upfront payment of $925 million to Anthos Therapeutics, with the latter also being entitled to receive up to approximately$2.15 billionin potential milestone payments.FDA Approves Expanded Use of Pfizer’s Cancer Drug Adcetris. An interim analysisof a phase III study on Sanofi and J&J’s vaccine candidate for extraintestinal pathogenicE. coli, conducted by an independent data monitoring committee,revealed that the vaccine failed to demonstrate sufficient efficacy in preventing invasive E. colidisease. As a result, the study is being discontinued. The companies said that no safety signals have been identified in the study. Sanofi and J&J entered into a co-development deal for the vaccine in Oc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-nvs-abbv-130300054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RHHBY","SNY","LU0310799852.SGD","IE00BBT3K403.USD","LU1057294990.SGD","SG9999001440.SGD","03165","BK4581","IE00B3PB1722.GBP","LU0225771236.USD","IE00B19Z3581.USD","LU0058720904.USD","LU2237443622.USD","LU0545039389.USD","LU0965509101.SGD","LU0029864427.USD","LU1989771016.USD","XLO","IE0004445239.USD","LU1244550494.USD","SG9999001176.SGD","LU1093756168.USD","NVS","LU0868494617.USD","IE00BVYPNV92.GBP","LU1496350171.SGD","LU1989772840.SGD","LU0689472784.USD","LU0306807586.USD","BK4585","LU1003077747.HKD","LU2089283258.USD","BK4592","LU1551013342.USD","PFE","BK4566","SGXZ57979304.SGD","LU1585245621.USD","LU1983299246.USD","LU1066053197.SGD","LU0256863811.USD","LU2237443465.HKD","BK4007","ABBV","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU0203347892.USD","LU0965509283.SGD","IE00B4R5TH58.HKD","LU0417517546.SGD","IE0002141913.USD"],"gpt_icon":1},{"id":"2511226575","title":"Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN) and Xilio Therapeutics (XLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511226575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511226575?lang=en_us&edition=fundamental","pubTime":"2025-02-13 23:50","pubTimestamp":1739461806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocugen (OCGN – Research Report) and Xilio Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ocugen-ocgn-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ocugen-ocgn-and-xilio-therapeutics-xlo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4568","XLO","BK4139","BK4137","OCGN","HCSG"],"gpt_icon":0},{"id":"2511588671","title":"Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie","url":"https://stock-news.laohu8.com/highlight/detail?id=2511588671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511588671?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:30","pubTimestamp":1739381405,"startTime":"0","endTime":"0","summary":"Shares in biotech group Xilio Therapeutics ($XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie Inc. ($ABBV). Xilio Tar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/xilio-xlo-stock-zooms-125-higher-on-cancer-fighting-deal-with-abbvie?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/xilio-xlo-stock-zooms-125-higher-on-cancer-fighting-deal-with-abbvie?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","BK4588","LU0029864427.USD","LU0122379950.USD","IE0002141913.USD","LU1267930573.SGD","XLO","LU0211327993.USD","BK4566","LU1430594728.SGD","LU0310800379.SGD","LU2468319806.SGD","IE00BGHQF631.EUR","LU1093756325.SGD","LU1551013425.SGD","LU1585245621.USD","LU0795875086.SGD","SG9999015986.USD","BK4139","SG9999015952.SGD","BK4585","LU0234572021.USD","BK4533","LU2237443549.SGD","ABBV","LU0203347892.USD","LU1244550494.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","SG9999001440.SGD","LU0820561909.HKD","LU1023059063.AUD","LU1732799900.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","LU1934455277.USD","IE00BSNM7G36.USD","LU1037948541.HKD","LU0310799852.SGD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","LU0861579265.USD","LU2112291526.USD","LU2237443978.SGD","LU1496350171.SGD","SG9999003800.SGD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0456855351.SGD"],"gpt_icon":0},{"id":"2511307134","title":"Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2511307134","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511307134?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:08","pubTimestamp":1739380080,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43666595/crude-oil-down-over-2-upstart-shares-jump-following-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOM","CVS","SMWB","UPST","TIVC","SPIR","XLO"],"gpt_icon":1},{"id":"2511301344","title":"Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511301344","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511301344?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:44","pubTimestamp":1739375086,"startTime":"0","endTime":"0","summary":"On Wednesday,AbbVieInc and Xilio Therapeutics, Inc. announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based immunotherapies, including masked T-cell engagers, leveraging Xilio’s proprietary technology.Xilio has developed a proprietary, clinically validated platform technology for tumor-activated biologics.The company is advancing a pipeline of clinical and preclinical immunotherapies, including masked multispecific molecules, designed to achieve tumor-selective activation by leveraging masking and other unique components that are optimized for the specific target.The action allows focused activity within the tumor microenvironment to minimize systemic adverse events.Under the terms of the agreement, Xilio will receive $52.0 million in upfront payments, including a $10 million equity investment, and will be eligible to receive up to approximately $2.1 billion in contingent payments for option-related fees and milestones plus tiered roya","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-nano-cap-cancer-focused-154446557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0985320562.USD","LU1244550494.USD","LU0965509010.AUD","LU1551013342.USD","XLO","LU2468319806.SGD","LENZ","IE00BSNM7G36.USD","LU0661504455.SGD","LU0820561818.USD","LU2112291526.USD","BK4139","LU0795875086.SGD","IE00B2B36J28.USD","LU0198837287.USD","LU0708994859.HKD","LU2347655156.SGD","SG9999015978.USD","LU0949170772.SGD","IE00BJJMRZ35.SGD","IE00BGHQF631.EUR","LU1267930573.SGD","BK4550","LU1989772923.USD","LU1093756325.SGD","IE0009355771.USD","IE00B42XCP33.USD","LU1093756168.USD","LU1496350171.SGD","LU1551013425.SGD","LU0203345920.USD","LU0861579265.USD","IE00B3PB1722.GBP","LU1057294990.SGD","LU1244550577.SGD","IE00BVYPNV92.GBP","BK4588","LU0456855351.SGD","SG9999015945.SGD","BK4533","LU0029864427.USD","LU0234570918.USD","BK4566","LU2089283258.USD","LU2089984988.USD","ABBV","LU1037948897.HKD","LU1983299246.USD","LU2133065610.SGD","LU0882574055.USD"],"gpt_icon":1},{"id":"2510964370","title":"Xilio Therapeutics Shares up 107% After Collaboration With Abbvie to Develop Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2510964370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510964370?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:31","pubTimestamp":1739370703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P319S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"XLO","fiscalQuarterEnding":"2025/03","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-11","symbol":"XLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-07","symbol":"XLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-08-08","symbol":"XLO","fiscalQuarterEnding":"2024/06","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-05-14","symbol":"XLO","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1671681600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XLO","date":"2025-05-09","current":-0.686464,"percent":0.637413,"low":-8.819798,"twenty":-1.071492,"median":-0.790557,"eighty":-0.542848,"high":-0.169617,"avg":-1.293769,"sd":1.558989,"marketCap":37277076},"quantilePoints":[{"date":"2021-10-22","current":-5.619943,"twenty":-5.655644,"median":-5.655644,"eighty":-5.634223,"marketCap":423962880},{"date":"2021-10-29","current":-5.897428,"twenty":-5.742879,"median":-5.655644,"eighty":-5.632588,"marketCap":444896047},{"date":"2021-11-05","current":-7.534236,"twenty":-7.275719,"median":-5.778004,"eighty":-5.653191,"marketCap":568375236},{"date":"2021-11-12","current":-7.783621,"twenty":-8.139785,"median":-6.784325,"eighty":-5.655644,"marketCap":587188588},{"date":"2021-11-19","current":-7.994369,"twenty":-8.332268,"median":-7.783621,"eighty":-5.669463,"marketCap":603087196},{"date":"2021-11-26","current":-6.993317,"twenty":-8.285904,"median":-7.699322,"eighty":-5.707754,"marketCap":527568808},{"date":"2021-12-03","current":-4.59754,"twenty":-8.14962,"median":-7.070591,"eighty":-5.652373,"marketCap":353417461},{"date":"2021-12-10","current":-3.644608,"twenty":-8.092015,"median":-6.680707,"eighty":-5.383906,"marketCap":280164654},{"date":"2021-12-17","current":-3.769058,"twenty":-8.017551,"median":-5.735855,"eighty":-4.164453,"marketCap":289731252},{"date":"2021-12-23","current":-5.689144,"twenty":-8.011931,"median":-5.689668,"eighty":-4.138852,"marketCap":437330192},{"date":"2021-12-31","current":-5.689144,"twenty":-7.994369,"median":-5.689144,"eighty":-4.156631,"marketCap":437330192},{"date":"2022-01-07","current":-5.091784,"twenty":-7.797671,"median":-5.658171,"eighty":-4.266858,"marketCap":391410521},{"date":"2022-01-14","current":-5.162898,"twenty":-7.783621,"median":-5.653587,"eighty":-4.59754,"marketCap":396877149},{"date":"2022-01-21","current":-4.842884,"twenty":-7.716182,"median":-5.64292,"eighty":-4.788126,"marketCap":372277325},{"date":"2022-01-28","current":-4.77177,"twenty":-7.567253,"median":-5.591843,"eighty":-4.822972,"marketCap":366810698},{"date":"2022-02-04","current":-3.598384,"twenty":-7.225139,"median":-5.49358,"eighty":-4.4546,"marketCap":276611346},{"date":"2022-02-11","current":-4.739768,"twenty":-7.024227,"median":-5.32737,"eighty":-4.153075,"marketCap":364350716},{"date":"2022-02-18","current":-4.82155,"twenty":-6.909018,"median":-5.17001,"eighty":-4.244813,"marketCap":370637337},{"date":"2022-02-25","current":-4.675765,"twenty":-6.763601,"median":-5.152231,"eighty":-4.222767,"marketCap":359430751},{"date":"2022-03-04","current":-3.096766,"twenty":-6.21074,"median":-5.107785,"eighty":-4.106851,"marketCap":234734857},{"date":"2022-03-11","current":-2.663652,"twenty":-5.825774,"median":-5.088228,"eighty":-3.781858,"marketCap":201904807},{"date":"2022-03-18","current":-2.77554,"twenty":-5.735355,"median":-5.013559,"eighty":-3.685854,"marketCap":210385903},{"date":"2022-03-25","current":-2.526499,"twenty":-5.698992,"median":-4.963778,"eighty":-3.539359,"marketCap":191508625},{"date":"2022-04-01","current":-2.475969,"twenty":-5.691597,"median":-4.880219,"eighty":-3.443152,"marketCap":187678452},{"date":"2022-04-08","current":-2.537327,"twenty":-5.689563,"median":-4.835772,"eighty":-3.159567,"marketCap":192329376},{"date":"2022-04-14","current":-2.180008,"twenty":-5.689144,"median":-4.77177,"eighty":-2.747387,"marketCap":165244585},{"date":"2022-04-22","current":-1.454542,"twenty":-5.689144,"median":-4.707766,"eighty":-2.648493,"marketCap":110254251},{"date":"2022-04-29","current":-1.27492,"twenty":-5.677766,"median":-4.57265,"eighty":-2.569089,"marketCap":96638949},{"date":"2022-05-06","current":-1.311037,"twenty":-5.658676,"median":-4.385974,"eighty":-2.547433,"marketCap":99376596},{"date":"2022-05-13","current":-1.14627,"twenty":-5.655644,"median":-4.188632,"eighty":-2.530108,"marketCap":92258714},{"date":"2022-05-20","current":-0.816335,"twenty":-5.654821,"median":-4.133519,"eighty":-2.502678,"marketCap":65703535},{"date":"2022-05-27","current":-1.102052,"twenty":-5.652774,"median":-3.930511,"eighty":-2.265187,"marketCap":88699772},{"date":"2022-06-03","current":-0.945588,"twenty":-5.649828,"median":-3.790392,"eighty":-1.806807,"marketCap":76106594},{"date":"2022-06-10","current":-1.017017,"twenty":-5.638325,"median":-3.710388,"eighty":-1.458346,"marketCap":81855654},{"date":"2022-06-17","current":-0.70749,"twenty":-5.619943,"median":-3.662386,"eighty":-1.354377,"marketCap":56943063},{"date":"2022-06-24","current":-0.812934,"twenty":-5.619943,"median":-3.598384,"eighty":-1.267697,"marketCap":65429770},{"date":"2022-07-01","current":-0.979602,"twenty":-5.563744,"median":-3.523713,"eighty":-1.159876,"marketCap":78844242},{"date":"2022-07-08","current":-1.17008,"twenty":-5.533214,"median":-3.456155,"eighty":-1.140148,"marketCap":94175067},{"date":"2022-07-15","current":-1.037426,"twenty":-5.49998,"median":-3.32776,"eighty":-1.085725,"marketCap":83498242},{"date":"2022-07-22","current":-1.057834,"twenty":-5.470823,"median":-3.149101,"eighty":-1.083005,"marketCap":85140831},{"date":"2022-07-29","current":-0.986405,"twenty":-5.364184,"median":-2.77554,"eighty":-1.046269,"marketCap":79391771},{"date":"2022-08-05","current":-1.102052,"twenty":-5.320424,"median":-2.696136,"eighty":-1.036746,"marketCap":88699772},{"date":"2022-08-12","current":-0.822578,"twenty":-5.273125,"median":-2.638387,"eighty":-1.029943,"marketCap":67383911},{"date":"2022-08-19","current":-0.792483,"twenty":-5.1885,"median":-2.582443,"eighty":-1.019739,"marketCap":64918646},{"date":"2022-08-26","current":-0.752358,"twenty":-5.16432,"median":-2.558983,"eighty":-0.995929,"marketCap":61631626},{"date":"2022-09-02","current":-0.692169,"twenty":-5.154364,"median":-2.548154,"eighty":-0.989126,"marketCap":56701096},{"date":"2022-09-09","current":-0.919548,"twenty":-5.147964,"median":-2.539131,"eighty":-0.97416,"marketCap":75327543},{"date":"2022-09-16","current":-1.003143,"twenty":-5.130186,"median":-2.530108,"eighty":-0.962595,"marketCap":82175502},{"date":"2022-09-23","current":-1.003143,"twenty":-5.105296,"median":-2.513866,"eighty":-0.964636,"marketCap":82175502},{"date":"2022-09-30","current":-0.973049,"twenty":-5.093206,"median":-2.475969,"eighty":-0.964636,"marketCap":79710236},{"date":"2022-10-07","current":-0.916204,"twenty":-5.08965,"median":-2.286481,"eighty":-0.962595,"marketCap":75053625},{"date":"2022-10-14","current":-0.769077,"twenty":-5.06476,"median":-1.858781,"eighty":-0.94028,"marketCap":63001218},{"date":"2022-10-21","current":-0.728951,"twenty":-5.046982,"median":-1.5525,"eighty":-0.91821,"marketCap":59714198},{"date":"2022-10-28","current":-0.782452,"twenty":-5.007158,"median":-1.454542,"eighty":-0.886404,"marketCap":64096891},{"date":"2022-11-04","current":-0.765733,"twenty":-4.979423,"median":-1.388688,"eighty":-0.850349,"marketCap":62727299},{"date":"2022-11-11","current":-0.800435,"twenty":-4.969467,"median":-1.311037,"eighty":-0.824584,"marketCap":68402762},{"date":"2022-11-18","current":-0.830646,"twenty":-4.957378,"median":-1.265891,"eighty":-0.82124,"marketCap":70984515},{"date":"2022-11-25","current":-0.849568,"twenty":-4.938888,"median":-1.206298,"eighty":-0.820572,"marketCap":72601537},{"date":"2022-12-02","current":-0.779332,"twenty":-4.887686,"median":-1.17008,"eighty":-0.816068,"marketCap":66599372},{"date":"2022-12-09","current":-0.737639,"twenty":-4.841462,"median":-1.144569,"eighty":-0.808598,"marketCap":63036442},{"date":"2022-12-16","current":-0.750468,"twenty":-4.837906,"median":-1.129263,"eighty":-0.802075,"marketCap":64132728},{"date":"2022-12-23","current":-0.753675,"twenty":-4.830083,"median":-1.115833,"eighty":-0.793821,"marketCap":64406800},{"date":"2022-12-30","current":-0.862717,"twenty":-4.811594,"median":-1.102052,"eighty":-0.792483,"marketCap":73725230},{"date":"2023-01-06","current":-0.871537,"twenty":-4.77177,"median":-1.090148,"eighty":-0.792483,"marketCap":74478927},{"date":"2023-01-13","current":-0.853096,"twenty":-4.74688,"median":-1.061235,"eighty":-0.792483,"marketCap":72903016},{"date":"2023-01-20","current":-0.894789,"twenty":-4.74119,"median":-1.053301,"eighty":-0.795158,"marketCap":76465945},{"date":"2023-01-27","current":-1.372651,"twenty":-4.688566,"median":-1.055567,"eighty":-0.795827,"marketCap":117302597},{"date":"2023-02-03","current":-1.16098,"twenty":-4.613185,"median":-1.081644,"eighty":-0.799513,"marketCap":99213879},{"date":"2023-02-10","current":-0.962138,"twenty":-4.577628,"median":-1.082826,"eighty":-0.801513,"marketCap":82221447},{"date":"2023-02-17","current":-1.148152,"twenty":-4.515758,"median":-1.061235,"eighty":-0.802368,"marketCap":98117593},{"date":"2023-02-24","current":-1.122495,"twenty":-4.501535,"median":-1.084009,"eighty":-0.802643,"marketCap":95925021},{"date":"2023-03-03","current":-0.945045,"twenty":-4.362862,"median":-1.082826,"eighty":-0.804607,"marketCap":83373763},{"date":"2023-03-10","current":-0.864219,"twenty":-4.26828,"median":-1.057834,"eighty":-0.807261,"marketCap":76243112},{"date":"2023-03-17","current":-0.913958,"twenty":-4.219922,"median":-1.04933,"eighty":-0.8088,"marketCap":80631205},{"date":"2023-03-24","current":-0.95748,"twenty":-4.169431,"median":-1.040827,"eighty":-0.809202,"marketCap":84470786},{"date":"2023-03-31","current":-0.985458,"twenty":-4.145964,"median":-1.035725,"eighty":-0.811441,"marketCap":86939088},{"date":"2023-04-06","current":-0.935719,"twenty":-4.134585,"median":-1.030623,"eighty":-0.814116,"marketCap":82550995},{"date":"2023-04-14","current":-1.032089,"twenty":-4.106851,"median":-1.030623,"eighty":-0.816068,"marketCap":91052925},{"date":"2023-04-21","current":-0.917067,"twenty":-4.017114,"median":-1.026546,"eighty":-0.816335,"marketCap":80905461},{"date":"2023-04-28","current":-0.948646,"twenty":-3.911443,"median":-1.02382,"eighty":-0.817495,"marketCap":83691451},{"date":"2023-05-05","current":-0.911322,"twenty":-3.845861,"median":-1.021746,"eighty":-0.820572,"marketCap":80398672},{"date":"2023-05-12","current":-0.980924,"twenty":-3.781858,"median":-1.017017,"eighty":-0.823915,"marketCap":87807424},{"date":"2023-05-19","current":-0.962532,"twenty":-3.746301,"median":-1.012271,"eighty":-0.827811,"marketCap":86161034},{"date":"2023-05-26","current":-0.94108,"twenty":-3.710744,"median":-1.010214,"eighty":-0.834494,"marketCap":84240763},{"date":"2023-06-02","current":-0.892033,"twenty":-3.707189,"median":-1.007219,"eighty":-0.840742,"marketCap":79850365},{"date":"2023-06-09","current":-0.921155,"twenty":-3.693676,"median":-1.004815,"eighty":-0.843978,"marketCap":82457163},{"date":"2023-06-16","current":-0.836856,"twenty":-3.65883,"median":-1.003143,"eighty":-0.837538,"marketCap":74911167},{"date":"2023-06-23","current":-0.833791,"twenty":-3.644608,"median":-0.99838,"eighty":-0.836856,"marketCap":74636767},{"date":"2023-06-30","current":-0.82766,"twenty":-3.607629,"median":-0.996609,"eighty":-0.830049,"marketCap":74087967},{"date":"2023-07-07","current":-0.78781,"twenty":-3.566382,"median":-0.993208,"eighty":-0.824593,"marketCap":70520769},{"date":"2023-07-14","current":-0.815398,"twenty":-3.536514,"median":-0.99316,"eighty":-0.822592,"marketCap":72990368},{"date":"2023-07-21","current":-0.842987,"twenty":-3.522291,"median":-0.989806,"eighty":-0.82124,"marketCap":75459967},{"date":"2023-07-28","current":-0.849118,"twenty":-3.486734,"median":-0.985931,"eighty":-0.822592,"marketCap":76008766},{"date":"2023-08-04","current":-0.842987,"twenty":-3.454022,"median":-0.985458,"eighty":-0.822602,"marketCap":75459967},{"date":"2023-08-11","current":-0.873641,"twenty":-3.441984,"median":-0.980924,"eighty":-0.823797,"marketCap":78203965},{"date":"2023-08-18","current":-0.878604,"twenty":-3.372515,"median":-0.979241,"eighty":-0.82539,"marketCap":74028579},{"date":"2023-08-25","current":-0.940627,"twenty":-3.299607,"median":-0.975457,"eighty":-0.826964,"marketCap":79254417},{"date":"2023-09-01","current":-0.937361,"twenty":-3.233197,"median":-0.973023,"eighty":-0.82766,"marketCap":78979228},{"date":"2023-09-08","current":-0.885104,"twenty":-3.159567,"median":-0.971728,"eighty":-0.82766,"marketCap":74576205},{"date":"2023-09-15","current":-0.829581,"twenty":-2.981269,"median":-0.970062,"eighty":-0.826617,"marketCap":69897993},{"date":"2023-09-22","current":-0.76426,"twenty":-2.79503,"median":-0.966806,"eighty":-0.822588,"marketCap":64394214},{"date":"2023-09-29","current":-0.70547,"twenty":-2.766156,"median":-0.965603,"eighty":-0.816906,"marketCap":59440813},{"date":"2023-10-06","current":-0.646681,"twenty":-2.727897,"median":-0.962595,"eighty":-0.815979,"marketCap":54487412},{"date":"2023-10-13","current":-0.604222,"twenty":-2.71346,"median":-0.962532,"eighty":-0.812453,"marketCap":50909955},{"date":"2023-10-20","current":-0.636883,"twenty":-2.666539,"median":-0.960045,"eighty":-0.808397,"marketCap":53661845},{"date":"2023-10-27","current":-0.679342,"twenty":-2.665096,"median":-0.95957,"eighty":-0.806065,"marketCap":57239301},{"date":"2023-11-03","current":-0.816517,"twenty":-2.648493,"median":-0.95748,"eighty":-0.802222,"marketCap":68797237},{"date":"2023-11-10","current":-0.522571,"twenty":-2.614566,"median":-0.947902,"eighty":-0.798373,"marketCap":44030232},{"date":"2023-11-17","current":-0.442347,"twenty":-2.594354,"median":-0.946599,"eighty":-0.792483,"marketCap":35925248},{"date":"2023-11-24","current":-0.401672,"twenty":-2.584248,"median":-0.945588,"eighty":-0.790684,"marketCap":32621777},{"date":"2023-12-01","current":-0.305101,"twenty":-2.570532,"median":-0.942446,"eighty":-0.788267,"marketCap":24778786},{"date":"2023-12-08","current":-0.311846,"twenty":-2.563314,"median":-0.941074,"eighty":-0.783066,"marketCap":25326611},{"date":"2023-12-15","current":-0.247443,"twenty":-2.556095,"median":-0.940627,"eighty":-0.780271,"marketCap":20096115},{"date":"2023-12-22","current":-0.180091,"twenty":-2.551764,"median":-0.938014,"eighty":-0.774301,"marketCap":14626118},{"date":"2023-12-29","current":-0.193209,"twenty":-2.551764,"median":-0.937361,"eighty":-0.770792,"marketCap":15691487},{"date":"2024-01-05","current":-0.245647,"twenty":-2.547433,"median":-0.936267,"eighty":-0.769457,"marketCap":19950212},{"date":"2024-01-12","current":-0.275645,"twenty":-2.54238,"median":-0.935334,"eighty":-0.766195,"marketCap":22386522},{"date":"2024-01-19","current":-0.233071,"twenty":-2.539492,"median":-0.934949,"eighty":-0.764849,"marketCap":18928889},{"date":"2024-01-26","current":-0.216937,"twenty":-2.534439,"median":-0.93261,"eighty":-0.754249,"marketCap":17618512},{"date":"2024-02-02","current":-0.227106,"twenty":-2.530108,"median":-0.92518,"eighty":-0.752358,"marketCap":18444380},{"date":"2024-02-09","current":-0.203378,"twenty":-2.528664,"median":-0.923284,"eighty":-0.751224,"marketCap":16517355},{"date":"2024-02-16","current":-0.199107,"twenty":-2.525055,"median":-0.920389,"eighty":-0.749014,"marketCap":16170491},{"date":"2024-02-23","current":-0.18643,"twenty":-2.519281,"median":-0.919085,"eighty":-0.746197,"marketCap":15140909},{"date":"2024-03-01","current":-0.240325,"twenty":-2.504121,"median":-0.917067,"eighty":-0.739651,"marketCap":19518008},{"date":"2024-03-08","current":-0.270832,"twenty":-2.496181,"median":-0.915351,"eighty":-0.735638,"marketCap":21995611},{"date":"2024-03-15","current":-0.219174,"twenty":-2.466585,"median":-0.913491,"eighty":-0.731225,"marketCap":17800203},{"date":"2024-03-22","current":-0.238122,"twenty":-2.421829,"median":-0.911599,"eighty":-0.715205,"marketCap":19339070},{"date":"2024-03-28","current":-0.216598,"twenty":-2.392955,"median":-0.911029,"eighty":-0.70547,"marketCap":17590983},{"date":"2024-04-05","current":-0.545745,"twenty":-2.180008,"median":-0.910426,"eighty":-0.68914,"marketCap":41697098},{"date":"2024-04-12","current":-0.613532,"twenty":-2.057292,"median":-0.907037,"eighty":-0.679342,"marketCap":46876301},{"date":"2024-04-19","current":-0.577442,"twenty":-1.858781,"median":-0.904632,"eighty":-0.663875,"marketCap":44118872},{"date":"2024-04-26","current":-0.455638,"twenty":-1.793814,"median":-0.901286,"eighty":-0.653213,"marketCap":34812547},{"date":"2024-05-03","current":-0.507198,"twenty":-1.570039,"median":-0.897996,"eighty":-0.636883,"marketCap":38751930},{"date":"2024-05-10","current":-0.608637,"twenty":-1.534961,"median":-0.892115,"eighty":-0.623819,"marketCap":46502316},{"date":"2024-05-17","current":-0.561705,"twenty":-1.473562,"median":-0.887764,"eighty":-0.608637,"marketCap":39859128},{"date":"2024-05-24","current":-0.556504,"twenty":-1.454542,"median":-0.885503,"eighty":-0.604222,"marketCap":39490062},{"date":"2024-05-31","current":-0.483742,"twenty":-1.448767,"median":-0.881558,"eighty":-0.597071,"marketCap":34326828},{"date":"2024-06-07","current":-0.53057,"twenty":-1.404749,"median":-0.876706,"eighty":-0.586439,"marketCap":37649763},{"date":"2024-06-14","current":-0.546175,"twenty":-1.387604,"median":-0.876079,"eighty":-0.580482,"marketCap":38757109},{"date":"2024-06-21","current":-0.496031,"twenty":-1.379022,"median":-0.873673,"eighty":-0.570621,"marketCap":35198837},{"date":"2024-06-28","current":-0.488956,"twenty":-1.374775,"median":-0.873641,"eighty":-0.569679,"marketCap":34696841},{"date":"2024-07-05","current":-0.448904,"twenty":-1.357353,"median":-0.873641,"eighty":-0.561773,"marketCap":31854652},{"date":"2024-07-12","current":-0.520114,"twenty":-1.333588,"median":-0.87282,"eighty":-0.555857,"marketCap":36907841},{"date":"2024-07-15","current":-0.53057,"twenty":-1.329066,"median":-0.872339,"eighty":-0.554184,"marketCap":37649763},{"date":"2024-08-02","current":-0.494158,"twenty":-1.324544,"median":-0.872339,"eighty":-0.551376,"marketCap":35065956},{"date":"2024-08-09","current":-0.483847,"twenty":-1.311037,"median":-0.871537,"eighty":-0.546175,"marketCap":31707006},{"date":"2024-08-16","current":-0.556692,"twenty":-1.27492,"median":-0.868973,"eighty":-0.546175,"marketCap":36480567},{"date":"2024-08-23","current":-0.597874,"twenty":-1.27323,"median":-0.865924,"eighty":-0.546175,"marketCap":39179250},{"date":"2024-08-30","current":-0.538985,"twenty":-1.267697,"median":-0.863468,"eighty":-0.546175,"marketCap":35320221},{"date":"2024-09-06","current":-0.518595,"twenty":-1.264807,"median":-0.862048,"eighty":-0.54616,"marketCap":33984066},{"date":"2024-09-13","current":-0.549985,"twenty":-1.263703,"median":-0.858314,"eighty":-0.545667,"marketCap":36041042},{"date":"2024-09-20","current":-0.524699,"twenty":-1.232207,"median":-0.857152,"eighty":-0.544779,"marketCap":34384033},{"date":"2024-09-27","current":-0.504376,"twenty":-1.201879,"median":-0.854893,"eighty":-0.540606,"marketCap":33052273},{"date":"2024-10-04","current":-0.486602,"twenty":-1.189844,"median":-0.850349,"eighty":-0.531977,"marketCap":31887532},{"date":"2024-10-11","current":-0.528522,"twenty":-1.186983,"median":-0.849328,"eighty":-0.53057,"marketCap":34634562},{"date":"2024-10-18","current":-0.529863,"twenty":-1.186643,"median":-0.84452,"eighty":-0.530429,"marketCap":34722467},{"date":"2024-10-25","current":-0.62108,"twenty":-1.173809,"median":-0.842987,"eighty":-0.530429,"marketCap":40700006},{"date":"2024-10-31","current":-0.918877,"twenty":-1.170289,"median":-0.84264,"eighty":-0.53057,"marketCap":60214912},{"date":"2024-11-08","current":-0.727841,"twenty":-1.17008,"median":-0.842987,"eighty":-0.53057,"marketCap":45710590},{"date":"2024-11-15","current":-0.669964,"twenty":-1.168468,"median":-0.840267,"eighty":-0.53057,"marketCap":42075719},{"date":"2024-11-22","current":-0.643941,"twenty":-1.163546,"median":-0.839921,"eighty":-0.531625,"marketCap":40441428},{"date":"2024-11-29","current":-0.76293,"twenty":-1.160538,"median":-0.835323,"eighty":-0.532657,"marketCap":47914300},{"date":"2024-12-06","current":-0.734933,"twenty":-1.159035,"median":-0.830725,"eighty":-0.534491,"marketCap":46155977},{"date":"2024-12-13","current":-0.720934,"twenty":-1.15649,"median":-0.82862,"eighty":-0.53653,"marketCap":45276816},{"date":"2024-12-20","current":-0.65654,"twenty":-1.152,"median":-0.82766,"eighty":-0.53657,"marketCap":41232673},{"date":"2024-12-27","current":-0.682437,"twenty":-1.147776,"median":-0.825921,"eighty":-0.53657,"marketCap":42859122},{"date":"2025-01-03","current":-0.748931,"twenty":-1.14627,"median":-0.822602,"eighty":-0.53657,"marketCap":47035139},{"date":"2025-01-10","current":-0.783928,"twenty":-1.145209,"median":-0.822578,"eighty":-0.537107,"marketCap":49233042},{"date":"2025-01-17","current":-0.797927,"twenty":-1.143284,"median":-0.817491,"eighty":-0.538636,"marketCap":50112204},{"date":"2025-01-24","current":-0.580737,"twenty":-1.142869,"median":-0.816517,"eighty":-0.540201,"marketCap":36472013},{"date":"2025-01-31","current":-0.486385,"twenty":-1.140266,"median":-0.816335,"eighty":-0.53657,"marketCap":30546465},{"date":"2025-02-07","current":-0.482956,"twenty":-1.13297,"median":-0.815659,"eighty":-0.532822,"marketCap":30331071},{"date":"2025-02-14","current":-0.902917,"twenty":-1.125202,"median":-0.815429,"eighty":-0.53057,"marketCap":56705915},{"date":"2025-02-21","current":-0.771637,"twenty":-1.122495,"median":-0.815398,"eighty":-0.531274,"marketCap":48461135},{"date":"2025-02-28","current":-0.649413,"twenty":-1.121121,"median":-0.810785,"eighty":-0.532657,"marketCap":40785074},{"date":"2025-03-07","current":-0.678968,"twenty":-1.117838,"median":-0.809202,"eighty":-0.534491,"marketCap":42641227},{"date":"2025-03-14","current":-0.710276,"twenty":-1.115867,"median":-0.80603,"eighty":-0.53653,"marketCap":41367199},{"date":"2025-03-21","current":-0.696942,"twenty":-1.110216,"median":-0.804926,"eighty":-0.53657,"marketCap":40590594},{"date":"2025-03-28","current":-0.648849,"twenty":-1.102052,"median":-0.802148,"eighty":-0.53657,"marketCap":37789636},{"date":"2025-04-04","current":-0.622447,"twenty":-1.09797,"median":-0.800186,"eighty":-0.536838,"marketCap":36251956},{"date":"2025-04-11","current":-0.588045,"twenty":-1.090488,"median":-0.797927,"eighty":-0.537939,"marketCap":34248313},{"date":"2025-04-17","current":-0.67374,"twenty":-1.087559,"median":-0.796877,"eighty":-0.53939,"marketCap":39239300},{"date":"2025-04-25","current":-0.744946,"twenty":-1.083536,"median":-0.792483,"eighty":-0.541079,"marketCap":43386374},{"date":"2025-05-02","current":-0.671162,"twenty":-1.080126,"median":-0.792322,"eighty":-0.54163,"marketCap":39089156},{"date":"2025-05-09","current":-0.686464,"twenty":-1.071492,"median":-0.790557,"eighty":-0.542848,"marketCap":37277076}],"updateTime":1747007860204}}}